![HeartSciences MyoVista wavECG Скачать руководство пользователя страница 32](http://html.mh-extra.com/html/heartsciences/myovista-wavecg/myovista-wavecg_user-manual_2114879032.webp)
23
USER MANUAL DO-LBL-06035(L)
| MyoVista® Wavelet ECG (
wav
ECG™) 12-Lead Cardiac Testing Device
General Overview
Ventricular Indices Statements (if applicable)
These indices (and numeric comparisons) have ranges which demonstrate an elevated risk of relaxation
abnormalities associated with LV diastolic dysfunction .
If any of the criteria for elevated risk related to the MyoVista Ventricular Indices specified are met,
then a statement listed in Table 3-4 will be displayed below the Repolarization Measures Algorithm
Statement (see Figure 3-7) .
Figure 3-7
Table 3-4 . Provides the relative-risk calculations for a patient having relaxation abnormalities
associated with LV diastolic dysfunction
Table 3-4
Sex
Rule
MyoVista Wavelet
Analysis Statement
Relative-
Risk
Men and Women
VIEM(RV) < 20
Abnormal VIEM(RV) < 20%
1 .4X
Men and Women
VILM(RV) < 17
Abnormal VILM(RV) < 17%
1 .3X
Women
VIEM(LV) < 22
Abnormal VIEM(LV) < 22%
1 .5X
Women
VILM(LV) < 21
Abnormal VILM(LV) < 21%
1 .5X
Women
[VIEM(RV) / VIEM(LV)] > 2 .5
Abnormal VIEM Ratio > 2 .5
1 .5X
Women
[VILM(RV) / VILM(LV)] > 2 .5
Abnormal VILM Ratio > 2 .5
1 .5X
Women
[VIEM(RV) – VILM(RV)] < 0 .4
Borderline RV VIEM-VILM
difference < 0 .4
1 .1X
Women
[VIEM(RV) – VILM(RV)] > 4 .5
Borderline RV VIEM-VILM
difference > 4 .5
1 .4X
Men
[VIEM(RV) – VILM(RV)] > 5 .3
Borderline RV VIEM-VILM
difference > 5 .3
1 .4X